Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 4
1996 1
1998 1
1999 1
2001 4
2002 1
2003 2
2004 2
2005 2
2007 6
2008 4
2009 4
2010 4
2011 4
2012 3
2013 1
2014 4
2015 6
2016 2
2017 2
2018 4
2019 1
2020 3
2021 4
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Molecular Pathways and Mechanisms of HER2 in Cancer Therapy.
Raghav KPS, Moasser MM. Raghav KPS, et al. Among authors: moasser mm. Clin Cancer Res. 2023 Jul 5;29(13):2351-2361. doi: 10.1158/1078-0432.CCR-22-0283. Clin Cancer Res. 2023. PMID: 36574481 Free PMC article. Review.
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumors.
Ruiz-Saenz A, Atreya CE, Wang C, Pan B, Dreyer CA, Brunen D, Prahallad A, Muñoz DP, Ramms DJ, Burghi V, Spassov DS, Fewings E, Hwang YC, Cowdrey C, Moelders C, Schwarzer C, Wolf DM, Hann B, VandenBerg SR, Shokat K, Moasser MM, Bernards R, Gutkind JS, van 't Veer LJ, Coppé JP. Ruiz-Saenz A, et al. Among authors: moasser mm. Nat Cancer. 2023 Feb;4(2):240-256. doi: 10.1038/s43018-022-00508-5. Epub 2023 Feb 9. Nat Cancer. 2023. PMID: 36759733 Free PMC article.
HER-2-directed, small-molecule antagonists.
Arkin M, Moasser MM. Arkin M, et al. Among authors: moasser mm. Curr Opin Investig Drugs. 2008 Dec;9(12):1264-76. Curr Opin Investig Drugs. 2008. PMID: 19037833 Free PMC article. Review.
Targeting HER2 by Combination Therapies.
Ruiz-Saenz A, Moasser MM. Ruiz-Saenz A, et al. Among authors: moasser mm. J Clin Oncol. 2018 Mar 10;36(8):808-811. doi: 10.1200/JCO.2017.77.1899. Epub 2018 Jan 30. J Clin Oncol. 2018. PMID: 29381433 Free PMC article. No abstract available.
CD318 is a ligand for CD6.
Enyindah-Asonye G, Li Y, Ruth JH, Spassov DS, Hebron KE, Zijlstra A, Moasser MM, Wang B, Singer NG, Cui H, Ohara RA, Rasmussen SM, Fox DA, Lin F. Enyindah-Asonye G, et al. Among authors: moasser mm. Proc Natl Acad Sci U S A. 2017 Aug 15;114(33):E6912-E6921. doi: 10.1073/pnas.1704008114. Epub 2017 Jul 31. Proc Natl Acad Sci U S A. 2017. PMID: 28760953 Free PMC article.
HER family in cancer progression: From discovery to 2020 and beyond.
Kumar R, George B, Campbell MR, Verma N, Paul AM, Melo-Alvim C, Ribeiro L, Pillai MR, da Costa LM, Moasser MM. Kumar R, et al. Among authors: moasser mm. Adv Cancer Res. 2020;147:109-160. doi: 10.1016/bs.acr.2020.04.001. Epub 2020 Jun 5. Adv Cancer Res. 2020. PMID: 32593399 Review.
Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers.
Campbell MR, Ruiz-Saenz A, Peterson E, Agnew C, Ayaz P, Garfinkle S, Littlefield P, Steri V, Oeffinger J, Sampang M, Shan Y, Shaw DE, Jura N, Moasser MM. Campbell MR, et al. Among authors: moasser mm. Cell Rep. 2022 Feb 1;38(5):110291. doi: 10.1016/j.celrep.2021.110291. Cell Rep. 2022. PMID: 35108525 Free PMC article.
73 results